Showing results (551-560 of 584) with videos related to

Sort By:
Pageof 59
Scientific Reports|February 23, 2023
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitroSheli R Radoshitzky, Patrick Iversen, Xianghan Lu, et al.
Plos Pathogens|January 13, 2022
Advances and gaps in SARS-CoV-2 infection modelsCésar Muñoz-Fontela, Lina Widerspick, Randy A Albrecht, et al.
Global Health Action|April 4, 2022
The legacy of ZikaPLAN: a transnational research consortium addressing ZikaAnnelies Wilder-Smith, Elizabeth B Brickley, Ricardo Arraes de Alencar Ximenes, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activitySuzanne J F Kaptein, Sofie Jacobs, Lana Langendries, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitorEd J Griffen, Daren Fearon, Briana L McGovern, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 proteaseNathaniel T Kenton, Haim Barr, Artem Cherepakha, et al.
The Lancet. Microbe|January 27, 2024
Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational studySimon Feys, Sam Vanmassenhove, Sirima Kraisin, et al.
The Journal of Clinical Investigation|August 15, 2023
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.
Biorxiv : the Preprint Server for Biology|June 23, 2021
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.
Nature Communications|July 10, 2025
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2Marwah Karim, Manjari Mishra, Chieh-Wen Lo, et al.
Pageof 59